Annual ROE
-14.73%
+31.16%+67.90%
December 31, 2023
Summary
- As of February 22, 2025, ACAD annual return on equity is -14.73%, with the most recent change of +31.16% (+67.90%) on December 31, 2023.
- During the last 3 years, ACAD annual ROE has risen by +27.74% (+65.32%).
- ACAD annual ROE is now -120.34% below its all-time high of 72.43%, reached on December 31, 2010.
Performance
ACAD ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
27.32%
+20.28%+288.07%
September 30, 2024
Summary
- As of February 22, 2025, ACAD quarterly return on equity is 27.32%, with the most recent change of +20.28% (+288.07%) on September 30, 2024.
- Over the past year, ACAD quarterly ROE has increased by +65.31% (+171.91%).
- ACAD quarterly ROE is now -90.44% below its all-time high of 285.83%, reached on September 30, 2004.
Performance
ACAD Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ACAD ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +67.9% | +171.9% |
| 3 y3 years | +65.3% | +185.5% |
| 5 y5 years | +75.5% | +148.5% |
ACAD ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +67.9% | at high | +156.8% |
| 5 y | 5-year | at high | +67.9% | at high | +156.8% |
| alltime | all time | -120.3% | +89.4% | -90.4% | +109.9% |
ACADIA Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 27.32%(+288.1%) |
| Jun 2024 | - | 7.04%(-1776.2%) |
| Mar 2024 | - | -0.42%(-97.3%) |
| Dec 2023 | -14.73%(-67.9%) | -15.60%(-58.9%) |
| Sep 2023 | - | -37.99%(+39.3%) |
| Jun 2023 | - | -27.28%(-22.2%) |
| Mar 2023 | - | -35.08%(-27.0%) |
| Dec 2022 | -45.89%(+59.6%) | -48.07%(+6.8%) |
| Sep 2022 | - | -45.03%(+12.4%) |
| Jun 2022 | - | -40.08%(+0.9%) |
| Mar 2022 | - | -39.73%(+36.4%) |
| Dec 2021 | -28.75%(-32.3%) | -29.13%(-8.9%) |
| Sep 2021 | - | -31.97%(-24.5%) |
| Jun 2021 | - | -42.33%(+3.0%) |
| Mar 2021 | - | -41.08%(-4.2%) |
| Dec 2020 | -42.47%(+6.4%) | -42.89%(+7.1%) |
| Sep 2020 | - | -40.04%(+9.5%) |
| Jun 2020 | - | -36.57%(-12.9%) |
| Mar 2020 | - | -41.99%(-4.5%) |
| Dec 2019 | -39.93%(-33.7%) | -43.98%(-21.9%) |
| Sep 2019 | - | -56.32%(-25.4%) |
| Jun 2019 | - | -75.48%(-7.6%) |
| Mar 2019 | - | -81.73%(+7.1%) |
| Dec 2018 | -60.22%(-11.2%) | -76.30%(-7.6%) |
| Sep 2018 | - | -82.59%(+11.4%) |
| Jun 2018 | - | -74.17%(+9.5%) |
| Mar 2018 | - | -67.71%(-1.6%) |
| Dec 2017 | -67.80%(-10.3%) | -68.78%(+7.9%) |
| Sep 2017 | - | -63.76%(-0.8%) |
| Jun 2017 | - | -64.26%(0.0%) |
| Mar 2017 | - | -64.26%(+1.8%) |
| Dec 2016 | -75.58%(+17.0%) | -63.11%(-1.6%) |
| Sep 2016 | - | -64.13%(-4.2%) |
| Jun 2016 | - | -66.94%(+8.8%) |
| Mar 2016 | - | -61.50%(-4.4%) |
| Dec 2015 | -64.58%(+71.7%) | -64.36%(+23.3%) |
| Sep 2015 | - | -52.20%(+20.3%) |
| Jun 2015 | - | -43.40%(+23.8%) |
| Mar 2015 | - | -35.05%(+16.6%) |
| Dec 2014 | -37.62%(+32.4%) | -30.07%(+11.2%) |
| Sep 2014 | - | -27.03%(+9.7%) |
| Jun 2014 | - | -24.63%(-1.8%) |
| Mar 2014 | - | -25.09%(-6.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | -28.41%(-26.2%) | -26.76%(-10.9%) |
| Sep 2013 | - | -30.03%(-7.4%) |
| Jun 2013 | - | -32.43%(-33.6%) |
| Mar 2013 | - | -48.81%(-26.8%) |
| Dec 2012 | -38.49%(-55.2%) | -66.69%(-31.4%) |
| Sep 2012 | - | -97.22%(+1.2%) |
| Jun 2012 | - | -96.03%(+16.2%) |
| Mar 2012 | - | -82.67%(+10.5%) |
| Dec 2011 | -85.82%(-218.5%) | -74.82%(-264.8%) |
| Sep 2011 | - | 45.40%(-24.9%) |
| Jun 2011 | - | 60.45%(-36.4%) |
| Mar 2011 | - | 94.98%(-34.9%) |
| Dec 2010 | 72.43%(-152.2%) | 145.90%(-152.9%) |
| Sep 2010 | - | -275.64%(+37.4%) |
| Jun 2010 | - | -200.68%(+16.0%) |
| Mar 2010 | - | -173.01%(+14.1%) |
| Dec 2009 | -138.68%(+80.2%) | -151.63%(+22.1%) |
| Sep 2009 | - | -124.19%(+15.0%) |
| Jun 2009 | - | -108.03%(+16.0%) |
| Mar 2009 | - | -93.14%(+19.8%) |
| Dec 2008 | -76.97%(+23.6%) | -77.77%(+13.2%) |
| Sep 2008 | - | -68.72%(+15.2%) |
| Jun 2008 | - | -59.66%(+7.7%) |
| Mar 2008 | - | -55.41%(+0.6%) |
| Dec 2007 | -62.28%(-26.4%) | -55.08%(+1.3%) |
| Sep 2007 | - | -54.37%(+0.6%) |
| Jun 2007 | - | -54.02%(-25.8%) |
| Mar 2007 | - | -72.76%(+1.2%) |
| Dec 2006 | -84.57%(-13.2%) | -71.88%(-0.8%) |
| Sep 2006 | - | -72.45%(-8.1%) |
| Jun 2006 | - | -78.82%(-8.0%) |
| Mar 2006 | - | -85.64%(+6.8%) |
| Dec 2005 | -97.46%(+15.4%) | -80.22%(+8.1%) |
| Sep 2005 | - | -74.18%(+20.4%) |
| Jun 2005 | - | -61.60%(-58.3%) |
| Mar 2005 | - | -147.58%(-25.4%) |
| Dec 2004 | -84.48%(-415.7%) | -197.78%(-169.2%) |
| Sep 2004 | - | 285.83%(+235.2%) |
| Jun 2004 | - | 85.28%(+187.0%) |
| Mar 2004 | - | 29.71%(+16.5%) |
| Dec 2003 | 26.76%(-16.6%) | 25.50% |
| Dec 2002 | 32.10%(-139.8%) | - |
| Dec 2001 | -80.65%(-278.1%) | - |
| Dec 2000 | 45.29% | - |
FAQ
- What is ACADIA Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals annual ROE year-on-year change?
- What is ACADIA Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals quarterly ROE year-on-year change?
What is ACADIA Pharmaceuticals annual return on equity?
The current annual ROE of ACAD is -14.73%
What is the all time high annual ROE for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high annual return on equity is 72.43%
What is ACADIA Pharmaceuticals annual ROE year-on-year change?
Over the past year, ACAD annual return on equity has changed by +31.16% (+67.90%)
What is ACADIA Pharmaceuticals quarterly return on equity?
The current quarterly ROE of ACAD is 27.32%
What is the all time high quarterly ROE for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high quarterly return on equity is 285.83%
What is ACADIA Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, ACAD quarterly return on equity has changed by +65.31% (+171.91%)